EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Breast cancer and gender-affirming hormone therapy for transgender and gender-diverse (TGD) individuals

Elizabeth J Cathcart-Rake, Kathryn J Ruddy, Amye J Tevaarwerk, Aminah Jatoi

Maturitas · 2024

DOI: 10.1016/j.maturitas.2024.107913 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Maturitas, 2024. Verfasst von Elizabeth J Cathcart-Rake und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Mayo Clinic, Rochester, MN, United States of America. Electronic address: Cathcart-rake.elizabeth@mayo.edu. Hauptthemen laut MEDLINE: Transgender Persons, Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NICHD NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transgender and gender-diverse (TGD) individuals are at risk for breast cancer, but are less likely to undergo screening mammograms and appear to suffer poorer cancer-related outcomes than cisgender women. Gender-affirming hormone therapy (GAHT) may be lifesaving for TGD individuals from the perspective of affirming their core identities; however, the effects of GAHT on cancer development, progression, and outcomes are poorly understood.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transgender PersonsBreast NeoplasmsFemaleHumansMammographyHormonesMale

Stichwörter der Autor:innen

Breast oncologyGender diverseTransgender

Substanzen

Hormones

Autor:innen und Institutionen

  • Department of Medical Oncology, Mayo Clinic, Rochester, MN, United States of America. Electronic address: Cathcart-rake.elizabeth@mayo.edu.
  • Department of Medical Oncology, Mayo Clinic, Rochester, MN, United States of America.

Förderung

  • NIA NIH HHS
  • NICHD NIH HHS
  • NIH

Zitieren

APA

Cathcart-Rake, E. J., Ruddy, K. J., Tevaarwerk, A. J., & Jatoi, A. (2024). Breast cancer and gender-affirming hormone therapy for transgender and gender-diverse (TGD) individuals. Maturitas. https://doi.org/10.1016/j.maturitas.2024.107913

Vancouver

Cathcart-Rake EJ, Ruddy KJ, Tevaarwerk AJ, Jatoi A. Breast cancer and gender-affirming hormone therapy for transgender and gender-diverse (TGD) individuals. Maturitas. 2024. doi:10.1016/j.maturitas.2024.107913

BibTeX
@article{CathcartRake2024,
  author = {Cathcart-Rake, Elizabeth J and Ruddy, Kathryn J and Tevaarwerk, Amye J and Jatoi, Aminah},
  title = {Breast cancer and gender-affirming hormone therapy for transgender and gender-diverse (TGD) individuals},
  journal = {Maturitas},
  year = {2024},
  doi = {10.1016/j.maturitas.2024.107913}
}
Kostenlos starten →